Background illustration for clinical trials search

Paid Clinical Trials Overland Park

Discover 722 paid clinical trials in Overland Park, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Fairway KS, Columbia MO, Peoria IL, Sioux Falls SD,
Sponsor: Immuneering Corporation

Sex: All

Age: 18+

Code: NCT07562152

Phase3, Recruiting
Active & Responsive

SynKIR-310 for Relapsed/Refractory B-NHL

for
B Cell Lymphoma, NHL, Adult, Mantle Cell Lymphoma,
Location: Fairway KS, Denver CO, Atlanta GA, Philadelphia PA,
Sponsor: Verismo Therapeutics

Sex: All

Age: 18+

Code: NCT06544265

Phase1, Recruiting
Active & Responsive

DMCRN-02-001: Assessing Pediatric Endpoints in DM1

for
Congenital Myotonic Dystrophy, CDM
Location: Fairway KS, Rochester NY, Richmond VA, Los Angeles CA
Sponsor: Virginia Commonwealth University

Sex: All

Age: 0 - 4

Code: NCT05224778

Recruiting
Active & Responsive

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

for
Generalized Myasthenia Gravis
Location: Kansas City KS, McKinney TX, Dallas TX, Cincinnati OH,
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Sex: All

Age: 18+

Code: NCT06463587

Phase3, Recruiting
Active & Responsive

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

for
Pulmonary Hypertension, Interstitial Lung Disease (ILD),
Location: Kansas City KS, Chicago IL, Ann Arbor MI, Houston TX,
Sponsor: Pulmovant, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07333183

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP),
Location: Kansas City KS, O'Fallon IL, Winston-Salem NC,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06538064

Recruiting
Active & Responsive

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

for
Lung Cancer Diagnosis
Location: Leawood KS, Wichita KS, Springfield IL,
Sponsor: Freenome Holdings Inc.

Sex: All

Age: 50+

Code: NCT06122077

Recruiting
Active & Responsive

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

for
Percutaneous Coronary Intervention,
Location: Overland Park KS, Columbia MO, Lincoln NE, Wichita KS,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06909565

Recruiting
Active & Responsive

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

for
Cardiovascular Disease
Location: Overland Park KS, Kansas City KS, Kansas City MO,
Sponsor: Amgen

Sex: All

Age: 50 - 70+

Code: NCT07136012

Phase3, Recruiting
Active & Responsive

Assessment of CCM in HF With Higher Ejection Fraction

for
Heart Failure, Heart Failure With Preserved Ejection Fraction,
Location: Overland Park KS, Kansas City KS, Kansas City MO,
Sponsor: Impulse Dynamics

Sex: All

Age: 18+

Code: NCT05064709

Recruiting
Active & Responsive

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

for
Diabetic Peripheral Neuropathic Pain
Location: Kansas City MO, Wichita KS, Flossmoor IL, Hazelwood MO,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT06628908

Phase3, Recruiting
Active & Responsive

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

for
Migraine
Location: Overland Park KS, Omaha NE, St Louis MO, Rochester MN,
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70

Code: NCT06972056

Recruiting
Active & Responsive

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Westwood KS, St Louis MO, Iowa City IA, Rochester MN,
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT06788990

Phase2, Phase3, Recruiting
Active & Responsive

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

for
Metastatic Breast Cancer
Location: Westwood KS, Memphis TN, Cincinnati OH, Aurora CO,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 60+

Code: NCT06377852

Phase3, Recruiting
Active & Responsive

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

for
Acute Myeloid Leukemia, Chronic Myeloid Leukemia,
Location: Westwood KS, Columbus OH
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18 - 65

Code: NCT03533816

Phase1, Recruiting
Active & Responsive

A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

for
Gastric Adenocarcinoma,
Location: Westwood KS, Chicago IL, Dallas TX, Milwaukee WI,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT05365581

Phase1, Recruiting
Active & Responsive

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

for
Metastatic Non-small Cell Lung Cancer
Location: Westwood KS, Overland MO, Lee's Summit MO,
Sponsor: NovoCure GmbH

Sex: All

Age: 18+

Code: NCT06216301

Phase3, Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Westwood KS, Wichita KS, Omaha NE, St Louis MO,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase3, Recruiting
Active & Responsive

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Westwood KS, Omaha NE, Iowa City IA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT06901531

Phase3, Recruiting
Active & Responsive

Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients

for
NSCLC, Stage III, Locally Advanced Lung Carcinoma
Location: Kansas City KS
Sponsor: Jun Zhang, MD, PhD

Sex: All

Age: 18+

Code: NCT04680377

Recruiting